AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
Sep 14, 2015
32163_dirs_2015-09-14_06aa4d93-9193-480c-bbc0-a2841c6ee7c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-09-10
Reporting Person: Heron Patrick J (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-10 | Stock Option (Right to Purchase) | $13.45 | A | 15000 | Acquired | 2025-09-10 | Common Stock (15000) | Direct |
Footnotes
F1: The options vest and become exercisable over a 4-year period commencing on August 4, 2015. Twenty-five percent (25%) of the options vest and become exercisable on August 4, 2016, and the balance of the shares vest in equal monthly installments (rounded up to the nearest whole option) over the remaining three years.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26